Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: Effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4185-4192

  Oku, Takamitsu ^a,b   Tjuvajev, Juri G ^a   Miyagawa, Tadashi ^a   Sasajima, Toshio ^a   Joshi, Arjun ^a   Joshi, Revathi ^a   Finn, Ronald ^a   Claffey, Kevin P ^c   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; COMPLEMENTARY DNA; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GALLIUM CITRATE GA 67; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; GENE THERAPY; GENETIC TRANSFECTION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; ISOTOPE LABELING; MELANOMA CELL; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALS; BLOOD VOLUME; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOKINES; MELANOMA; MICE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RNA, ANTISENSE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032530218     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg., 175: 409-416, 1972.
2. Wang Y., and Becker, D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med., 3: 887-893, 1997.
3. Gho, Y. S., Lee J. E., Oh K. S., Bae, D. G., and Chae, C. B. Development of antiangiogenin peptide using a phage-displayed peptide library. Cancer Res., 57: 17, 3733-3740, 1997.
4. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
5. Saleh, M. Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
6. 121. Cancer Res., 55: 5296-5301, 1995.
7. Borgström, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
8. Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
9. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K-T., Manseau, E. J., and Dvorak, H. F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56: 172-181, 1996.
10. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
11. O'Reilly, M. S. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. Exper. Supp. (Basel), 79: 273-294, 1997.
12. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier. W. A., Polverini, P. J., and Bouck, N. Peptides from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol., 122: 497-511, 1993.
13. Senger, D. R., Connolly, D. T., Van de Water, L, Feder, J., and Dvorak, H. F. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res., 50: 1774-1778, 1990.
14. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10: 135-147, 1995.
15. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
16. Takahashi, T., and Shibuya, M. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene, 14: 2079-2089, 1997.
17. Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem., 270: 6729-6733, 1995.
18. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
19. Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kohno, K., Kuwano, M., and Fukui, M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res., 55: 1189-1193, 1995.
20. Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
21. Hamacher, K., Coenen, H. H., and Stoklin, G. Efficient stereospecific synthesis of no-carrie-added 2-[18F]-fluoro-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med., 27: 235-238, 1986.
22. Kothari, P., Ginos, J., Finn, R., Larson, S., Link, J., Krohn, K., and Garmestani, K. Cryptand [2.2.2] quantitation in the synthesis of 2-[18F]-fluoro-deoxy-D-glucose. Presented at the Fourth International Workshop on Targetry and Target Chemistry, Villigen, Switzerland, September 9-12, 1991.
23. Blasberg, R. G., Kobayashi, T., Patlak, C. S., Shinohara, M., Miyoaka, M., Rice, J. M., and Shapiro, W. R. Regional blood flow, capillary permeability, and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications. Cancer Treat. Rep., 1: 3-12, 1981.
24. Uehara, H., Miyagawa, T., Tjuvajev, J., Joshi, R., Beattie, B., Oku, T., Finn, R. and Blasberg, R. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and α-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions. J. Cereb. Blood Flow Metab., 17: 1239-1253, 1997.
25. 14C] antipyrine. Am. J. Physiol., 234: 59-66, 1978.
26. Kety, S. S. The theory and applications of the exchange of inert gas at the lungs and tissue. Pharmacol. Rev., 3: 1-41, 1959.
27. Kety, S. S. Measurement of local flow by the exchange of an inert diffusible substance. Methods Med. Res., 8: 228-236, 1960.
28. Gjedde, A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res. Rev., 14: 237-274, 1982.
29. Blasberg, R. G., Patlak, C. S., and Fenstermacher, J. D. The selection of experimental conditions for the accurate determination of blood-brain transfer constants from single-time experiments: a theoretical analysis. J. Cereb. Blood Flow Metab., 3: 215-225, 1983.
30. Blasberg, R. G., Groothuis, D., and Molnar, P. Application of quantitative autoradiographic measurements in experimental brain tumor models. Semin. Neurol., 1: 203-224, 1981.
31. Blasberg, R. G., Shinohara, M., Shapiro, W. R., Patlak, C. S., and Fenstcrmacher, J. D. Apparent glucose utilizations in Walker 256 brain tumors. J. Neuro-oncol., 4: 5-16, 1986.
32. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem., 28: 897-916, 1977.
33. Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., and Giovinco, P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J. Immunol., 122: 166-174, 1979.
34. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
35. Senger, D. R., Perruzzi, C. A., Feder, J., and Dvorak, H. F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cells lines. Cancer Res., 46: 5629-5632, 1986.
36. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
37. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor)) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.
38. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A., Dvorak, H., Senger, D., Connolly, J., and Schnitt, S. Expression expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol., 26: 86-91, 1995.
39. Dvorak, H. F., Sioussat, T. M., Brown, L. F., Nagy, J. A., Sotrel, A., Manseau, E., Van De Water, L., and Senger, D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med., 174: 1275-1278, 1991.
40. Dvorak, H., Brown, L. F., Detmar, M., and Dvorak, A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
41. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
42. Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., and Oldfield, E. H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest., 91: 153-159, 1993.
43. Claffey, K. P., Wilkison, W. O., and Spiegelman, B. M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem., 267: 16317-16322, 1992.
44. Sternberger, N. H., Sternberger, L. A., Kies, M. W., and Shear, C. R. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J. Neuroimmunol., 21: 241-248, 1989.
45. Sternberger, N. H., and Sternberger, L. A. Blood-brain barrier protein recognized by monoclonal antibody. Proc. Natl. Acad. Sci. USA, 84: 8169-8173, 1987.
46. Nakagawa H., Groothuis D. R., Owens E. S., Patlak C. S., Pettigrew K. D., and Blasberg R. G. Dexamethasone effects on vascular volume and tissue hematocrit in experimental RG-2 gliomas and adjacent brain. J. Neuro-oncol., 6: 157-168, 1988.
47. Nomura, T., Inamura, T., and Black, K. L. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res., 659: 62-66, 1994.
48. Nakagawa, H., Lin, S-Z., Bereczki, D., Gesztelyi, G., Otsuka, T., Wei, L., Hans, F-J., Acuff, V. R., Chen, J-L., Pettigrew, K. D., Patlak, C. S., Blasberg, R. G., and Fenstermacher, J. D. Blood volumes, hematocrits, and transit-times in parenchymal microvascular systems of the rat brain. In: D Le Bihan (ed.), Diffusion and Perfusion Magnetic Resonance Imaging, pp 193-200. New York: Raven Press, Ltd., 1995.
49. Wesseling, P., van der Laak, J. A. W. M., de Leeuw, H., Ruiter, D. J., and Burger, P. C. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer assisted analysis of whole-tumor sections. J. Neurosurg., 81: 902-909, 1994.
50. Roberts, W. G., and Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res., 57: 765-772, 1997.
51. Sellke, F. W., Wang, S. Y., Stamler, A., Lopez, J. J., Li, J., Li, J., and Simons, M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am. J. Physiol., 271: 713-720, 1996.
52. Ginsberg, M. D., Reivich, M., Giandomenico, A., and Greenberg, J. H. Local glucose utilization in acute focal cerebral ischemia: local dysmetabolism and diaschisis. Neurology, 27: 1042-1048, 1997.
53. Kubota, R., Kubota, K., Yamada, S., Tada, M., Ido, T., and Tamahashi, N. Microautoradio-graphic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J. Nucl. Med., 35: 104-112, 1994.
54. Clavo, A. C., and Wahl, R. L. Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells. J. Nucl. Med., 37: 502-506, 1996.
55. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol., 15: 5363-5368, 1995.
56. Yoshiji, H., Harris, S. R., and Thorgeirsson, U. P. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res., 57: 3924-3928, 1997.
57. Zhang, H. T., Craft, P., Scott, P. A., Ziehe, M., Weich, H. A., Harris, A. L., and Bicknell, R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst., 87: 213-219, 1995.
58. Pötgens, A. J., van Altena, M. C., Lubsen, N. H., Ruiter, D. J., and de Waal, R. M. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am. J. Pathol., 148: 1203-1217, 1996.
59. Harada, S., Nagy, J. A., Sullivan, K. A., Thomas, K. A., Endo, N., Rodan, G. A., and Rodan, S. B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Invest., 93: 2490-2496, 1994.
60. Brogi, E., Wu, T., Namiki, A., and Isner, J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation, 90: 649-652, 1994.
61. Dolecki, G. J., and Connolly, D. T. Effects of variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem. Res. Commun., 180: 572-578, 1991.
62. Detmar, M., Brown, L., Claffey, K., Yeo, K-T., Kocher, O., Jackman, R., Berse, B., and Dvorak, H. Overexpression of vascular permeability factor and its receptors in psoriasis. J. Exp. Med., 180: 1141-1146, 1994.
63. Finkenzeller, G., Marme, D., Weich, H. A., and Hug, H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res., 52: 4821-4823, 1992.
64. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem., 270: 12607-12613, 1995.
65. Li, J., Perrella, M. A., Tsai, J. C., Yet, S. F., Hsieh, C. M., Yoshizumi, M. Patterson, C. Endege, W. O., Zhou, F., and Lee, M. E. Induction of vascular endothelial growth factor fene expression by interleukin-1 beta in rat aortic smooth muscle cells. J. Biol. Chem., 270: 308-312, 1995.
66. Petrovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-b in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
67. Starvi, G. T., Hong, Y., Zachary, I. C., Breier, G., Baskerville, P. A., Yla, H. S., Risau, W., Martin, J. F., and Erusalimsky, J. D. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett., 358: 311-315, 1995.
68. Starvi, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., and Erusalimsky, J. D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation, 92: 11-14, 1995.
69. Williams, B., Quinn, B. A., and Gallacher, B. Serum and platelet-derived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro. Clin. Sci. (Colch), 88: 141-147, 1995.